| 000 | 00933 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250512005736.0 | ||
| 264 | 0 | _c19890823 | |
| 008 | 198908s 0 0 eng d | ||
| 022 | _a0002-8703 | ||
| 024 | 7 |
_a10.1016/0002-8703(89)90213-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFreis, E D | |
| 245 | 0 | 0 |
_aHexamethonium, a forgotten drug in relation to "new" concepts in the management of heart failure. _h[electronic resource] |
| 260 |
_bAmerican heart journal _cAug 1989 |
||
| 300 |
_a426-7 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aGanglionic Blockers _xtherapeutic use |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHexamethonium |
| 650 | 0 | 4 |
_aHexamethonium Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 773 | 0 |
_tAmerican heart journal _gvol. 118 _gno. 2 _gp. 426-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-8703(89)90213-5 _zAvailable from publisher's website |
| 999 |
_c2574690 _d2574690 |
||